You are not logged in!
Do you want to login? It's free!

Fri, 1 August 2014.
Check the latest stories & news.

Search implu: Advanced

Who do you implu?    Create a Free Account!

Government News : United States : Federal Government : Health and Human Services : National Institutes of Health (NIH) News Releases

Featured Article

Drug halts organ damage in inflammatory genetic disorder

A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease (NOMID). This rare and debilitating genetic disorder causes persistent inflammation and ongoing tissue damage. The research was performed by scientists at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health.

2012-02-10

Recent News, filter by:

Create a free account and automatically get e-mail alerts on news like this!

  • Sorry, there's no results; consider starting over.